BOSTON — Parties recently filed a proposed case management agreement in a Zofran lawsuit pending in a Massachusetts federal court.

Judge Robert Jenner must approve the agreed discovery order, which would preserve the confidentiality of both patient information from the plaintiffs and trade secrets from the defendant, GlaxoSmithKline.

In addition to this information, the proposed agreement also applies to unreleased clinical studies, GSK’s “design, development, research and testing” data, personnel information, and documents submitted to the Food and Drug Administration but exempted from disclosure under the Freedom of Information Act.

Generally, the party producing documents during discovery may withhold them based on a “reasonable belief” that the information is confidential.

Although there is broad agreement on most issues, the parties differ on who should bear the cost of copying documents and what information can be redacted in these papers.

Zofran Lawsuit

A number of these cases have been consolidated in a multi-district litigation panel in Boston. Judge Jenner will oversee pretrial matters, including discovery and settlement conferences. If the parties in an individual suit cannot resolve the matter, it will return to its place of origin for trial.

This anti-nausea drug was developed for chemotherapy patients, but GSX began aggressively marketing it as a treatment for hyperemesis gravidarum and other forms of NVP (nausea and vomiting during pregnancy, a.k.a. morning sickness). Essentially, the plaintiffs claim that GSX failed to warn patients about a known risk of serious side effects, in an attempt to pump up sales.

Specifically, Zofran has been linked to serious birth defects. Indeed, internal documents in support of GSK’s original 1991 approval application cited evidence of fetal toxicity and premature birth that were sometimes fatal.

Victims in dangerous drug lawsuits are entitled to compensation for their economic and noneconomic losses. Substantial punitive damage awards are also common in these cases.

Our Zofran Lawyers Can Help

Our dangerous drug attorneys can help if you or someone you care about was harmed while taking Zofran. Lawsuits have been filed against the drug makers by both patients and their families seeking compensation for injuries caused by the dangerous drug. You may be entitled to a settlement.

Our No-Fee Promise in Zofran Cases

You can afford to have our great team of Zofran lawyers on your side. When you choose us, it literally costs nothing to get started. We promise you in writing:

  • No money to get started,
  • We pay all case costs and expenses,
  • No legal fees whatsoever unless you receive a settlement, and
  • Phone calls are always free.

Start Your Zofran Lawsuit Claim

Our Zofran lawyers will help you file your lawsuit. To get started, you can:

  • Submit the Free Case Review Box on this page, or
  • Call (866) 280-4722 any time of day to tell us about your case.

We will listen to your story and answer your questions. If you have claim, we will start immediately.

WARNING: There are strict time deadlines for filing Zofran lawsuit claims.